We are live on ! Find out more
ZYME icon

Zymeworks

103 hedge funds and large institutions have $1.08B invested in Zymeworks in 2019 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 9

122% more capital invested

Capital invested by funds: $487M → $1.08B (+$595M)

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

39% more funds holding

Funds holding: 74103 (+29)

10.14% more ownership

Funds ownership: 50.26%60.4% (+10%)

0% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 25

44% less call options, than puts

Call options by funds: $4.13M | Put options by funds: $7.44M

Holders
103
Holders Change
+29
Holders Change %
+39.19%
% of All Funds
2.03%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
39
Increased
25
Reduced
25
Closed
9
Calls
$4.13M
Puts
$7.44M
Net Calls
-$3.3M
Net Calls Change
-$2.93M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$134M +$416K +11,455 +0.4%
PA
2
Perceptive Advisors
New York
$109M +$514K +14,136 +0.6%
GPP
3
Great Point Partners
Connecticut
$101M -$8.83M -242,955 -10%
BBA
4
Baker Bros. Advisors
New York
$77.7M
FCM
5
Farallon Capital Management
California
$77.3M -$1.14M -31,500 -2%
Fidelity International
6
Fidelity International
Bermuda
$73.5M +$58.7M +1,616,779 New
PC
7
Polar Capital
United Kingdom
$42.5M +$32.2M +884,955 +1,770%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$39.8M +$8.09M +222,547 +34%
CAM
9
Cormorant Asset Management
Massachusetts
$31.8M +$25.4M +700,000 New
Franklin Resources
10
Franklin Resources
California
$26.7M -$1.8M -49,500 -8%
MWNA
11
Marshall Wace North America
New York
$25.4M +$14.5M +399,993 +253%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$24.6M +$5.27M +144,961 +37%
Renaissance Technologies
13
Renaissance Technologies
New York
$24.2M +$5.67M +156,088 +42%
Millennium Management
14
Millennium Management
New York
$20.3M -$33.9M -933,195 -68%
LGM
15
Logos Global Management
California
$17.7M +$14.1M +389,153 New
Two Sigma Investments
16
Two Sigma Investments
New York
$17.2M +$8.67M +238,535 +170%
PAMU
17
Pictet Asset Management (UK)
United Kingdom
$15.8M -$4.7M -129,339 -27%
Citadel Advisors
18
Citadel Advisors
Florida
$15M +$12M +329,138 New
SC
19
Samlyn Capital
New York
$14.4M +$11.5M +316,979 New
BNP Paribas Asset Management
20
BNP Paribas Asset Management
France
$13.9M -$4.76M -131,017 -30%
Wells Fargo
21
Wells Fargo
California
$13.3M +$9.39M +258,421 +756%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$13M +$9.16M +252,200 +735%
WP
23
Woodline Partners
California
$12.4M +$9.92M +273,118 New
Victory Capital Management
24
Victory Capital Management
Texas
$11.8M +$2.31M +63,553 +32%
CS
25
Candriam SCA
Luxembourg
$10.6M +$8.44M +232,255 New

ZYME Hedge Fund Activity: Q4 2019 in Review

103 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q4 2019, worth a combined $1.08B — up 122% from $487M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ZYME positions and 9 closed out — a net gain of 30 holders — while 25 added to existing stakes and 25 trimmed.

The largest buyer was Fidelity International, opening a new position worth an estimated $58.7M. The largest seller was Camber Capital Management, exiting entirely with an estimated $37.2M sold.

  • 103 institutional investors held Zymeworks (ZYME) as of Q4 2019, up from 74 in Q3 2019.
  • Funds reported $1.08B of Zymeworks stock for Q4 2019, up 122% quarter-over-quarter.
  • 39 funds opened new Zymeworks positions in Q4 2019 and 9 closed out, a net change of +30 holders.
  • The largest Zymeworks buyer in Q4 2019 was Fidelity International, an estimated $58.7M added.
  • The largest Zymeworks seller in Q4 2019 was Camber Capital Management, an estimated $37.2M sold.

Based on aggregated 13F filings for Q4 2019.